Skip to main content

Antagonists of CCR4 as Immunomodulatory Agents

Buy Article:

$63.00 plus tax (Refund Policy)


The chemokine receptor CCR4 is broadly expressed on cells of the immune system. It is known to play a central role in T cell migration to the thymus, and T cell maturation and education. In addition, CCR4 is known to modulate T cell migration to several sites of inflammation in the body, including the skin, and lungs. It is best known as a drug target for airway inflammation and atopic dermatitis, but cells expressing CCR4 are found in many inflammatory diseases. CCR4 small molecule antagonists have not yet reached the clinic, but at least one has been validated in an in vivo model. Here we review the current status of structurally novel CCR4 receptor antagonists.

Keywords: CCR4 antagonists; Diaminopyrimidines; Lactams; Thiazolidinones; inflammation model; thiophenesulfonamide

Document Type: Research Article

Affiliations: Bristol-Myers Squibb, P.O. Box 4000, Princeton, NJ, 08543-4000, USA.

Publication date: July 1, 2006


Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more
Real Time Web Analytics